ArticleClinical case reports2023

Targeted treatment of refractory primitive neuroectodermal tumor arising from an immature teratoma with crizotinib leading to a sustained response.

Benjamin M Snyder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.